HHS, DOD invest more than $562M to increase COVID-19 test manufacturing

The funding — part of the American Rescue Plan to boost manufacturing of key products that increase domestic testing supply — went to a dozen U.S. companies to support the production of supplies including pipette tips, protective packaging, swabs and reagents, according to a news release. • OraSure Technologies: $109 million for retrofitting facilities to increase manufacturing capacity for at-home, rapid antigen self-tests. • Cepheid: $63.8 million to increase production of plastic overmold, an essential material for rapid test kits. • CSP Technologies: $19.27 million to scale up production of Activ-Film for packaging that ensures test integrity. • Porex: $16.2 million to increase production of pipette tip filters that prevent specimen contamination.